Cardinal Health (NYSE:CAH) Price Target Raised to $150.00

Cardinal Health (NYSE:CAH - Get Free Report) had its price objective boosted by equities researchers at Mizuho from $142.00 to $150.00 in a report issued on Monday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Mizuho's price objective suggests a potential upside of 13.71% from the company's previous close.

Several other brokerages have also recently issued reports on CAH. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. Argus set a $148.00 target price on Cardinal Health in a research report on Tuesday, February 4th. Morgan Stanley raised their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. JPMorgan Chase & Co. upped their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Finally, Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a report on Tuesday, January 7th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $140.14.

Remove Ads

Cardinal Health Price Performance

NYSE CAH traded down $5.18 on Monday, reaching $131.91. The stock had a trading volume of 1,401,475 shares, compared to its average volume of 2,117,265. The company has a market cap of $31.87 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The firm has a fifty day moving average of $129.14 and a two-hundred day moving average of $121.44. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Research analysts predict that Cardinal Health will post 7.95 EPS for the current fiscal year.

Hedge Funds Weigh In On Cardinal Health

Several large investors have recently bought and sold shares of the company. Rothschild Investment LLC raised its holdings in Cardinal Health by 10.1% in the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after buying an additional 79 shares during the last quarter. CSS LLC IL raised its position in shares of Cardinal Health by 0.8% during the fourth quarter. CSS LLC IL now owns 11,190 shares of the company's stock worth $1,323,000 after acquiring an additional 90 shares during the last quarter. Private Trust Co. NA lifted its stake in shares of Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after acquiring an additional 92 shares during the period. Checchi Capital Advisers LLC boosted its holdings in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after acquiring an additional 93 shares during the last quarter. Finally, TIAA Trust National Association raised its holdings in Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock worth $258,000 after purchasing an additional 94 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.